Literature DB >> 16472181

Functional cloning as a means to identify Leishmania genes involved in drug resistance.

Joachim Clos1, Kohelia Choudhury.   

Abstract

Resistance to anti-leishmanial drugs is a mounting problem in high-endemicity regions of South Asia and, potentially, in the context of HIV-Leishmania coinfections in Southern Europe. The molecular basis for clinical drug resistance is still largely unknown. It is important, however, to identify all relevant drug resistance markers for further drug development and for epidemiological surveys. An elegant and powerful method to identify such drug resistance markers without bias is functional cloning, using cosmid-based genomic DNA libraries. This review discusses the merits and caveats of this approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472181     DOI: 10.2174/138955706775476028

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  7 in total

1.  Reduced antimony accumulation in ARM58-overexpressing Leishmania infantum.

Authors:  Carola Schäfer; Paloma Tejera Nevado; Dorothea Zander; Joachim Clos
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.

Authors:  Élodie Gazanion; Christopher Fernández-Prada; Barbara Papadopoulou; Philippe Leprohon; Marc Ouellette
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

3.  PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Authors:  Bakela Nare; Levi A Garraway; Tim J Vickers; Stephen M Beverley
Journal:  Curr Genet       Date:  2009-04-25       Impact factor: 3.886

Review 4.  Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites.

Authors:  Magali Van den Kerkhof; Yann G-J Sterckx; Philippe Leprohon; Louis Maes; Guy Caljon
Journal:  Microorganisms       Date:  2020-06-24

5.  A novel marker, ARM58, confers antimony resistance to Leishmania spp.

Authors:  Andrea Nühs; Carola Schäfer; Dorothea Zander; Leona Trübe; Paloma Tejera Nevado; Sonja Schmidt; Jorge Arevalo; Vanessa Adaui; Louis Maes; Jean-Claude Dujardin; Joachim Clos
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-06       Impact factor: 4.077

Review 6.  Reverse Epidemiology: An Experimental Framework to Drive Leishmania Biomarker Discovery in situ by Functional Genetic Screening Using Relevant Animal Models.

Authors:  Laura Piel; Pascale Pescher; Gerald F Späth
Journal:  Front Cell Infect Microbiol       Date:  2018-09-19       Impact factor: 5.293

7.  High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.

Authors:  Christopher Fernandez-Prada; Mansi Sharma; Marie Plourde; Eva Bresson; Gaétan Roy; Philippe Leprohon; Marc Ouellette
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-16       Impact factor: 4.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.